Guardian Partners Inc. Astrazeneca PLC Transaction History
Guardian Partners Inc.
- $983 Billion
- Q4 2024
A detailed history of Guardian Partners Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Guardian Partners Inc. holds 47,564 shares of AZN stock, worth $3.46 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
47,564Holding current value
$3.46 Million% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,344Shares Held
478MCall Options Held
5.39MPut Options Held
3.79M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.57 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.98 Billion2.12% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.71 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.68 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.39 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $225B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...